Phosphagenics Limited announced that it has appointed three new directors to the board. The new directors include Dr. Greg Collier, Mr. Peter Lankau and Dr. Ross Murdoch. Dr. Greg Collier is currently the CEO of and has more than 20 years' experience spanning operational, clinical and scientific aspects of pharmaceutical research, development and commercialization.

He has executed multiple commercial transactions and has successfully taken a drug from discovery through to regulatory approval. Mr. Peter Lankau served as CEO of Endo Pharmaceuticals Inc. from 2005 to 2008 and as Chief Operating Officer from 2003 to 2005. In recent years Mr. Lankau has served on multiple company boards including Nautilus Neuroscience Inc. Dr. Ross Murdoch has over 25 years' experience in the global Healthcare, Pharmaceutical and Biotech industries and has held senior and executive positions with global Pharmaceutical companies such as GlaxoSmithKline, Astra Zeneca and Shire Pharmaceuticals where he built significant specialized business divisions.